PeptiDream Inc
TSE:4587
Intrinsic Value
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. [ Read More ]
The intrinsic value of one PeptiDream Inc stock under the Base Case scenario is 1 577.24 JPY. Compared to the current market price of 1 595.5 JPY, PeptiDream Inc is Overvalued by 1%.
Valuation Backtest
PeptiDream Inc
Run backtest to discover the historical profit from buying and selling PeptiDream Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
PeptiDream Inc
Current Assets | 27.2B |
Cash & Short-Term Investments | 19.5B |
Receivables | 5B |
Other Current Assets | 2.7B |
Non-Current Assets | 42.2B |
Long-Term Investments | 11.9B |
PP&E | 17.4B |
Intangibles | 10.6B |
Other Non-Current Assets | 2.4B |
Current Liabilities | 8.6B |
Accounts Payable | 3.2B |
Other Current Liabilities | 5.4B |
Non-Current Liabilities | 20.5B |
Long-Term Debt | 19.6B |
Other Non-Current Liabilities | 862.8m |
Earnings Waterfall
PeptiDream Inc
Revenue
|
28.7B
JPY
|
Cost of Revenue
|
-11.5B
JPY
|
Gross Profit
|
17.2B
JPY
|
Operating Expenses
|
-10.4B
JPY
|
Operating Income
|
6.8B
JPY
|
Other Expenses
|
-3.7B
JPY
|
Net Income
|
3B
JPY
|
Free Cash Flow Analysis
PeptiDream Inc
Profitability Score
Profitability Due Diligence
PeptiDream Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
PeptiDream Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
PeptiDream Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Score
PeptiDream Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
PeptiDream Inc
According to Wall Street analysts, the average 1-year price target for PeptiDream Inc is 2 717.57 JPY with a low forecast of 1 414 JPY and a high forecast of 5 145 JPY.
Shareholder Return
Price
PeptiDream Inc
Average Annual Return | -21.45% |
Standard Deviation of Annual Returns | 21.38% |
Max Drawdown | -83% |
Market Capitalization | 206.8B JPY |
Shares Outstanding | 129 607 353 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. The company is headquartered in Kawasaki-Shi, Kanagawa-Ken and currently employs 141 full-time employees. The company went IPO on 2013-06-11. The firm operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The firm is involved in the business centered on drug development based on special peptides. The firm's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Contact
IPO
Employees
Officers
The intrinsic value of one PeptiDream Inc stock under the Base Case scenario is 1 577.24 JPY.
Compared to the current market price of 1 595.5 JPY, PeptiDream Inc is Overvalued by 1%.